Ownership history in MORGAN STANLEY · 22 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 1,575,904 | +1,393,574 | +764.3% | 0.01% | $168.2M | — |
| 2025 Q2 | REDUCED | 182,330 | -1,441,797 | -88.8% | 0.00% | $17.2M | — |
| 2025 Q1 | ADDED | 1,624,127 | +140,374 | +9.5% | 0.01% | $103.1M | — |
| 2024 Q4 | ADDED | 1,483,753 | +892,844 | +151.1% | 0.00% | $68.9M | — |
| 2024 Q3 | REDUCED | 590,909 | -273,122 | -31.6% | 0.00% | $17.0M | — |
| 2024 Q2 | ADDED | 864,031 | +530,859 | +159.3% | 0.00% | $12.5M | — |
| 2024 Q1 | REDUCED | 333,172 | -148,024 | -30.8% | 0.00% | $5.4M | — |
| 2023 Q4 | ADDED | 481,196 | +407,153 | +549.9% | 0.00% | $9.6M | — |
| 2023 Q3 | REDUCED | 74,043 | -6,885 | -8.5% | 0.00% | $1.2M | — |
| 2023 Q2 | REDUCED | 80,928 | -124,968 | -60.7% | 0.00% | $1.7M | — |
As of 2025 Q3 — sorted by position size